Systemic Lupus Erythematosus CD8+ T Cells

About Systemic Lupus Erythematosus CD8+ T Cells

Systemic Lupus Erythematosus (SLE) CD8+ T Cells

Disease-State Human CD8+ T Cells for Autoimmune Cytotoxicity Research

Human CD8+ T Cells are purified from peripheral blood of IRB-consented donors clinically diagnosed with systemic lupus erythematosus (SLE). Cytotoxic T lymphocytes contribute to immune dysregulation and tissue damage observed in systemic autoimmune disease. SLE CD8+ T cells support investigations of inflammatory signaling pathways, cytotoxic immune activation, and therapeutic strategies aimed at modulating autoimmune responses.

Product Features

  • Research Use Only (RUO), CD8 positive T cells
  • Isolated from clinically confirmed SLE donors
  • High purity and viability (≥90% CD8+ cells)
  • Cryopreserved in CryoStor® CS10 media
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified clinical diagnosis and health history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Applications

  • Autoimmune cytotoxicity studies
  • Immune activation profiling
  • Cytokine signaling analysis
  • Therapeutic response evaluation
  • Single-cell immune profiling

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11–compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human CD8+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.

Donor Metadata

  • Verified diagnosis and clinical history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human CD8+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Systemic Lupus Erythematosus CD8+ T Cells with normal donor samples for comparison

Healthy CD8+ T Cells

3 In Stock
Screened normal donors · Cryopreserved · Starting at $950
View Inventory

Need a custom CD8+ T Cells cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information